Novartis AG ADR

Yahoo Finance • 13 days ago

Sector Update: Health Care Stocks Softer Late Afternoon

Health care stocks declined late Wednesday afternoon with the NYSE Health Care Index dropping 0.5% a PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 13 days ago

Sector Update: Health Care Stocks Softer Wednesday Afternoon

Health care stocks declined Wednesday afternoon, with the NYSE Health Care Index and the State Stree PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 14 days ago

Market Chatter: Pfizer, GSK, Others to Raise US Prices on 350 Drugs in 2026

Pfizer (PFE), Sanofi (SNY), Novartis (NVS), and GSK (GSK) are among the drug makers planning price i PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 21 days ago

How Investors May Respond To Salesforce (CRM) Q3 Beat And Surging Enterprise AI Adoption

In recent weeks, Salesforce reported record third-quarter fiscal 2026 results, raised its full-year guidance, and highlighted rapid adoption of its AI products Agentforce and Data 360, underpinned by new deployments at organizations such a... Full story

Yahoo Finance • 21 days ago

Stock Market Today, Dec. 23: Novo Nordisk Surges After FDA Approves Oral Wegovy Weight Loss Pill

Novo Nordisk(NYSE:NVO), which develops and markets diabetes and obesity treatments, closed Tuesday’s session at $51.61, up 7.30% after U.S. approval of its once-daily oral Wegovy weight-loss pill. Novo Nordisk IPO'd in 1981 and has grown 3... Full story

Yahoo Finance • 23 days ago

2 Top Stocks to Buy and Hold for the Long Term

Key Points Novartis has proved that it can navigate headwinds such as patent cliffs and a slow economy. Shopify's long-term ambitions are off to a great start, given its large addressable market and economic moat. 10 stocks we like better... Full story

Yahoo Finance • 25 days ago

Nine Major Drugmakers Agree To Lower Drug Prices Through TrumpRx Initiative

(RTTNews) - President Donald Trump announced nine new agreements with major pharmaceutical companies aimed at lowering prescription drug prices for Americans. The White House said the agreements will ensure that U.S. patients pay prices in... Full story

Yahoo Finance • 25 days ago

Trump reaches deal with 9 drug companies to lower prices

President Trump announced deals with nine major drug makers in a move to reduce pharmaceutical prices, granting a three-year break on trade tariffs if they invest more into US manufacturing. Market Domination Overtime host Jared Blikre bre... Full story

Yahoo Finance • 25 days ago

Stock market today: Dow, S&P 500, Nasdaq rise as Oracle, Nvidia lead AI trade resurgence

US stocks rose on Friday after snapping a recent losing streak, as signs of cooling inflation and waning AI worries buoyed Wall Street optimism toward the tail end of a topsy-turvy week. The S&P 500 (^GSPC) put on 0.8% and the Nasdaq Comp... Full story

Yahoo Finance • 25 days ago

IMG Saxony-Anhalt: 2026 in Sight - Saxony-Anhalt Sets the Pace for Future Industries

Despite challenging framework conditions such as high energy prices, the international introduction of tariffs, and bureaucratic requirements, Saxony-Anhalt is drawing a positive balance for 2025: leading companies have announced or begun... Full story

Yahoo Finance • 25 days ago

Novartis' myasthenia gravis asset iptacopan granted FDA Orphan Drug status

[Myasthenia gravis is shown using the text] Andrii Dodonov * The US FDA has granted [https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=961823] Orphan Drug designation to Novartis' (NVS [https://seekingal... Full story

Yahoo Finance • 25 days ago

Stock market today: Dow, S&P 500, Nasdaq rise as Nvidia, Oracle shine in tech revival

US stocks rose on Friday after snapping a recent losing streak, as signs of cooling inflation and waning AI worries buoyed Wall Street optimism toward the tail end of a topsy-turvy week. The S&P 500 (^GSPC) put on 0.9%, and the Nasdaq Com... Full story

Yahoo Finance • 25 days ago

Novartis and US government reach agreement on lowering drug prices in the US

Novartis Pharma AG Novartis agrees to take actions aimed at meeting US Administration priorities for drug pricing Additional Novartis medicines will be made available through direct-to-patient platforms in 2026 Company remains committed... Full story

Yahoo Finance • 27 days ago

Viatris Says FDA Approves Octreotide Acetate, Clears MR-146 for Clinical Trials

Viatris (VTRS) said Thursday the US Food and Drug Administration approved octreotide acetate for inj PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 27 days ago

Stock Market Today: Dow Slips As Nasdaq Struggles; Oracle Hit, Salesforce Up (Live Coverage)

Stock Market Today: The Dow Jones index rose Wednesday after the indexes dropped Tuesday. Tesla stock wavered. Continue Reading... Full story

Yahoo Finance • 28 days ago

Salesforce’s Agentforce Life Sciences Selected by Novartis to Drive More Personalized Customer Engagement Globally

SAN FRANCISCO, December 17, 2025--(BUSINESS WIRE)--Salesforce (NYSE: CRM), the world’s #1 AI CRM, announced today that Novartis (NYSE: NVS), a leading global innovative medicines company, has selected Salesforce’s Agentforce Life Sciences... Full story

Yahoo Finance • last month

Notable healthcare headlines for the week: CVS, Eli Lilly and Novartis in focus

Wall Street's major averages ended lower on Friday, with the S&P 500 (SP500 [https://seekingalpha.com/symbol/SP500]) and the Nasdaq (COMP:IND [https://seekingalpha.com/symbol/COMP:IND]) ending the week in the red as the AI trade came under... Full story

Yahoo Finance • last month

Novartis (NVS) Enters $1.7 Billion Development Deal, Says Report

We recently published 13 Best ADR Stocks to Invest In.  Novartis AG (NYSE:NVS) is one of the best ADR stocks. Swiss pharmaceutical giant Novartis AG (NYSE:NVS) has entered into a massive $1.7 billion partnership with British pharmaceutica... Full story

Yahoo Finance • last month

Novartis breaks ground on flagship manufacturing hub in North Carolina

Novartis Pharma AG Figure 1Novartis executives, federal, state and local officials gather for a groundbreaking at the company's flagship manufacturing hub in Durham, North Carolina, Thursday, December 11, 2025 Figure 2Novartis CEO Vasant... Full story

Yahoo Finance • last month

Sen-Jam Pharmaceutical Secures Major Strategic Partnership with TASK Clinical to Fund Two-Thirds of Phase 3 Trial for SJP-001

Equity-backed commitment dramatically de-risks pivotal program, boosts licensing appeal, and strengthens commercialization readiness. HUNTINGTON, N.Y., Dec. 11, 2025 /PRNewswire/ -- Sen-Jam Pharmaceutical, a clinical-stage biotechnology c... Full story